+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • April 2023
  • GlobalData
  • Athersys Inc
  • ID: 4308201
Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary therapies in the field of regenerative medicine. It is investigating its lead platform, MultiStem, a patented stem cell product for treating chronic conditions such as cardiovascular diseases, inflammatory and immune disorders, neurological, and pulmonary disorders. The company’s MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, traumatic brain injury, vascular disease, acute pulmonary distress, wound healing, organ reperfusion, bone marrow/hematopoietic stem cell transplantation, ischemic stroke, and autoimmune disease. The company's pipeline consists of therapeutic product development programs in multiple disease areas, through the application of proprietary technologies. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

  • Jan 30, 2023: Athersys top participate in International Stroke Conference and BioProcess International
  • Jan 05, 2023: Athersys Appoints Joseph Nolan to Its Board of Directors
  • Nov 15, 2022: Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update
  • Nov 11, 2022: Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.’s Biotech Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Athersys Inc - Key Facts
  • Athersys Inc - Key Employees
  • Athersys Inc - Key Employee Biographies
  • Athersys Inc - Major Products and Services
  • Athersys Inc - History
  • Athersys Inc - Company Statement
  • Athersys Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Athersys Inc - Business Description
  • Business Segment: Contract Revenue
  • Performance
  • Business Segment: Grant Revenue
  • Performance
  • R&D Overview
  • Athersys Inc - Corporate Strategy
  • Athersys Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Athersys Inc - Strengths
  • Athersys Inc - Weaknesses
  • Athersys Inc - Opportunities
  • Athersys Inc - Threats
  • Athersys Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Athersys Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 30, 2023: Athersys top participate in International Stroke Conference and BioProcess International
  • Jan 05, 2023: Athersys Appoints Joseph Nolan to Its Board of Directors
  • Nov 15, 2022: Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update
  • Nov 11, 2022: Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.’s Biotech Conference
  • Aug 11, 2022: Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update
  • Jun 21, 2022: Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures
  • Jun 09, 2022: Athersys Postpones Annual Meeting of Stockholders
  • Jun 02, 2022: Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinical Programs
  • May 06, 2022: Athersys Reports First Quarter 2022 Results
  • Apr 01, 2022: Athersys to Participate in Two Upcoming Investor Conferences
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Athersys Inc, Key Facts
  • Athersys Inc, Key Employees
  • Athersys Inc, Key Employee Biographies
  • Athersys Inc, Major Products and Services
  • Athersys Inc, History
  • Athersys Inc, Subsidiaries
  • Athersys Inc, Key Competitors
  • Athersys Inc, Ratios based on current share price
  • Athersys Inc, Annual Ratios
  • Athersys Inc, Interim Ratios
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Athersys Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Athersys Inc, Performance Chart (2018 - 2022)
  • Athersys Inc, Ratio Charts
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Plus Therapeutics Inc
  • SanBio Inc
  • Pfizer Inc
  • Pluri Inc
  • Lisata Therapeutics Inc
  • Caladrius Biosciences, 18301 Von Karma Ave., Suite 130, Irvine, California, United States
  • Arena Pharmaceuticals Inc
  • Plus Therapeutics Inc
  • SanBio Inc
  • Pfizer Inc
  • Pluri Inc
  • Vericel Corp
  • Cryo-Cell International Inc
  • Vericel Corp
  • Cryo-Cell International Inc
  • Arena Pharmaceuticals Inc
  • Caladrius Biosciences Inc
  • Mesoblast Ltd